The global glucuronolactone market is anticipated to reach $6,17,293.3 thousand by 2032, growing from $3,80,308.6 thousand in 2022 at a CAGR of 5.2% from 2023 to 2032.
Glucuronolactone is a chemical found in food products and is also manufactured in laboratories. Glucuronolactone is used as an ingredient in various consumer products, including some energy drinks, dietary supplements, and functional beverages... Glucuronolactone is included in supplements alongside taurine and caffeine. It can also be used in conjunction with other pre-workout substances like as creatine, beta-alanine, and citrulline. Glucuronolactone is a common ingredient found in many energy drinks such as Red bull and a number of pre-workout supplements, and fat-loss proteins, and it is found to increase bodily strength and intellectual focus.
A growing sedentary lifestyle and consumption of an unhealthy diet are driving market growth. The increasing demand for immediate energy-releasing products such as Rockstar, Red Bull, and Monster has contributed to market expansion. Furthermore, increased demand for clean-label and plant-based goods, as well as a growing inclination for a healthy, active lifestyle, are predicted to drive market expansion throughout the projection period. Furthermore, the increased usage of social media platforms such as Instagram and YouTube by manufacturers to advertise sports items is likely to drive market expansion throughout the forecast period by increasing the popularity of products. Moreover, the increasing disposable income of the consumers, and rising focus on sports nutrition encourage new product development, coupled with the rising awareness of sports nutrition.
The high glucuronolactone prices and different adverse impacts of excessive glucuronolactone intake, like disorientation, dizziness, and fast heartbeat, are expected to hamper market growth. The regulatory landscape surrounding dietary supplements and functional ingredients like glucuronolactone is evolving. Governments and regulatory bodies are placing greater emphasis on safety, efficacy, and accurate labeling. As regulations become more stringent, companies operating in the glucuronolactone market might face challenges in obtaining the necessary approvals and certifications for their products. These regulatory hurdles can lead to delays in product launches and additional costs associated with compliance, hindering the growth prospects of the market.
Rising pharmaceutical investments are contributing to the glucuronolactone industry's expansion. This can be due to the growing use of glucuronolactone in medicine manufacture, where it is employed as an addition to preserve uniformity and other properties. Rising innovation by key companies in glucuronolactone is expected to drive market growth. For instance, on 28 March 2019, to compete directly with market leaders Coca Cola launched its first energy drink in the United Kingdom, driving demand for glucuronolactone. The new drink, which contains caffeine, glucuronolactone, guarana extracts, and B vitamins, is intended for those aged 18 to 35.
The COVID-19 pandemic has had significant impacts on the market for glucuronolactone, influencing various aspects of its dynamics. Supply chain disruptions emerged as a significant challenge, with lockdowns, restrictions on travel, and reduced workforce availability affecting the sourcing of raw materials necessary for glucuronolactone production. These disruptions, combined with manufacturing facility closures and reduced operational capacities due to health and safety protocols, led to production slowdowns and potential shortages of glucuronolactone-containing products. The pandemic-induced shift in consumer behavior towards health and wellness further influenced the demand for dietary supplements and functional ingredients like glucuronolactone. With consumers increasingly seeking products that support immunity and overall well-being, the market experienced fluctuations in demand. Additionally, the closure of physical retail outlets prompted a greater reliance on online sales channels for distributing products, accelerating the trend towards e-commerce within the industry.
The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Frères. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.
Glucuronolactone is a chemical found in food products and is also manufactured in laboratories. Glucuronolactone is used as an ingredient in various consumer products, including some energy drinks, dietary supplements, and functional beverages... Glucuronolactone is included in supplements alongside taurine and caffeine. It can also be used in conjunction with other pre-workout substances like as creatine, beta-alanine, and citrulline. Glucuronolactone is a common ingredient found in many energy drinks such as Red bull and a number of pre-workout supplements, and fat-loss proteins, and it is found to increase bodily strength and intellectual focus.
A growing sedentary lifestyle and consumption of an unhealthy diet are driving market growth. The increasing demand for immediate energy-releasing products such as Rockstar, Red Bull, and Monster has contributed to market expansion. Furthermore, increased demand for clean-label and plant-based goods, as well as a growing inclination for a healthy, active lifestyle, are predicted to drive market expansion throughout the projection period. Furthermore, the increased usage of social media platforms such as Instagram and YouTube by manufacturers to advertise sports items is likely to drive market expansion throughout the forecast period by increasing the popularity of products. Moreover, the increasing disposable income of the consumers, and rising focus on sports nutrition encourage new product development, coupled with the rising awareness of sports nutrition.
The high glucuronolactone prices and different adverse impacts of excessive glucuronolactone intake, like disorientation, dizziness, and fast heartbeat, are expected to hamper market growth. The regulatory landscape surrounding dietary supplements and functional ingredients like glucuronolactone is evolving. Governments and regulatory bodies are placing greater emphasis on safety, efficacy, and accurate labeling. As regulations become more stringent, companies operating in the glucuronolactone market might face challenges in obtaining the necessary approvals and certifications for their products. These regulatory hurdles can lead to delays in product launches and additional costs associated with compliance, hindering the growth prospects of the market.
Rising pharmaceutical investments are contributing to the glucuronolactone industry's expansion. This can be due to the growing use of glucuronolactone in medicine manufacture, where it is employed as an addition to preserve uniformity and other properties. Rising innovation by key companies in glucuronolactone is expected to drive market growth. For instance, on 28 March 2019, to compete directly with market leaders Coca Cola launched its first energy drink in the United Kingdom, driving demand for glucuronolactone. The new drink, which contains caffeine, glucuronolactone, guarana extracts, and B vitamins, is intended for those aged 18 to 35.
The COVID-19 pandemic has had significant impacts on the market for glucuronolactone, influencing various aspects of its dynamics. Supply chain disruptions emerged as a significant challenge, with lockdowns, restrictions on travel, and reduced workforce availability affecting the sourcing of raw materials necessary for glucuronolactone production. These disruptions, combined with manufacturing facility closures and reduced operational capacities due to health and safety protocols, led to production slowdowns and potential shortages of glucuronolactone-containing products. The pandemic-induced shift in consumer behavior towards health and wellness further influenced the demand for dietary supplements and functional ingredients like glucuronolactone. With consumers increasingly seeking products that support immunity and overall well-being, the market experienced fluctuations in demand. Additionally, the closure of physical retail outlets prompted a greater reliance on online sales channels for distributing products, accelerating the trend towards e-commerce within the industry.
The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Frères. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the glucuronolactone market analysis from 2022 to 2032 to identify the prevailing glucuronolactone market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the glucuronolactone market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global glucuronolactone market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Investment Opportunities
- Supply Chain Analysis & Vendor Margins
- Technology Trend Analysis
- Consumer Preference and Product Specifications
- Market share analysis of players by products/segments
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- Market share analysis of players at global/region/country level
- SWOT Analysis
Key Market Segments
By Type
- Powder
- Liquid
- Tablet/Capsule
By Application
- Preservatives
- Antioxidants
- Processing Aids and Additives
- Energy Supplements
By End User
- Food and Beverages
- Pharmaceuticals
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA
- Key Market Players
- Jungbunzlauer
- Shandong Xinhong Pharmaceutical Co., Ltd.
- Shandong Fuyuan Bio-Tech CO.LTD.
- Merck Millipore Corporation
- Shaoxing Marina Biotechnology Co.Ltd.
- Shandong Baisheng Biotechnology Co., Ltd.
- Roquette Freres
- Functional Food chem International Corporation
- Hubei Yitai Pharmaceutical Co.Ltd.
- Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE
CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION
CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER
CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, the glucuronolactone market was valued at $380.3 million in 2022, and is estimated to reach $617.3 million by 2032, growing at a CAGR of 5.2% from 2023 to 2032.The organic metabolite glucuronolactone, also known as"D-glucuronolactone" or"D-glucuronic acid," is present in the body. This odorless solid white substance is a significant element in energy drinks and stimulants like Red Bull. Glucuronolactone is a naturally occurring chemical compound found in connective tissues such as animal and human cartilage, ligaments, and tendons. The substance is also generated from plant gums and is classified as a glucuronic acid lactone.
Glucuronolactone is used as one of the main ingredients in various energy drinks and supplements owing to its various benefits. Integration of IoT, ML, and AI technology in medical processes and equipment drives market development. These technologies have brought about significant improvements in various aspects of healthcare, including patient care, diagnostics, treatment, and operational efficiency. IoT, ML, and AI have contributed to the growth of the medical industry by aiding remote patient monitoring, personalized medicine, data security and privacy. Furthermore, increased chronic disease occurrences, as well as a growing geriatric population, are contributing to overall market growth. The widespread use of glucuronolactone in the food and beverage industries, such as in curing, pickling, and leavening agent, is expected to drive market expansion. Furthermore, the widespread use of home care settings, point-of-care diagnostics, and increased awareness of glucuronolactone in prescription medications for treating bone disease, hepatitis, and collagen disease are predicted to drive market expansion during the projection period.
However, glucuronolactone-based drugs may cause anxiety, insomnia, muscle twitching, or an increase in heart rate, which can be dangerous to people with high blood pressure. The safest amount of glucuronolactone supplementation is 500 to 600 mg per day. When used in large quantities, it might produce headaches, stomach cramps, and irritation. Furthermore, it might cause aggressive behavior and insomnia, which are expected to hinder market growth.
The glucuronolactone industry is expanding due to the increasing investments in the pharmaceutical industry. This can be due to the growing use of glucuronolactone in the manufacture of medicines, where it is used as a stabilizer and for other purposes. Additionally, the overall market is expanding as a result of the increased prevalence of chronic diseases and the rising elderly population. Additionally, it is anticipated that the widespread use of glucuronolactone in the food and beverage industry, such as in curing, pickling, and leavening agent, will support market expansion. Furthermore, it is predicted that the demand for glucuronolactone will expand throughout the forecast period due to rising health consciousness and increased interest in enhancing physical fitness. Additionally, Hubei Yitai Pharmaceutical Co., Ltd offers glucuronolactone used as a food additive, which is widely used in health foods and functional beverages. The product regulates immune function, anti-aging, moistening skin, improving oxygen to the brain, and helps in recovering from fatigue. All these factors are predicted to create an excellent opportunity for market growth during the forecast period.
The glucuronolactone market share is segmented on the basis of type, application, end use, and region. By type, it is classified into powder, liquid, and tablet & capsule. By application, it is classified into preservatives, antioxidants, processing aids & additives, energy supplements, and others. By end user. It is classified into food & beverages, pharmaceuticals, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players profiled in the glucuronolactone market report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., and Roquette Frères.
The report offers a comprehensive analysis of the global glucuronolactone market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also highlights on the present scenario and upcoming trends & developments that are contributing toward the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.
Impact of COVID-19 on the Global Glucuronolactone Industry
Initially, COVID-19 led to disruptions in supply chains, manufacturing, and distribution, which led to challenges in sourcing raw materials and maintaining production levels. Lockdowns and reduced economic activity also impacted consumer spending on dietary supplements and related products, affecting the demand.The pandemic underscored the importance of health and immunity, interest in supplements like glucuronolactone, known for potential cognitive and energy-enhancing benefits, grew. The shift towards remote work and focus on personal well-being contributed to this trend. Manufacturers adapted by emphasizing online sales channels and promoting the immune-boosting aspects of their products, aiding industry recovery.
In the post-COVID-19 pandemic, the glucuronolactone market is expected to undergo several changes. With an increased focus on health and well-being, there could be a surge in demand for dietary supplements and functional ingredients like glucuronolactone, as consumers seek products that support their immune systems and overall health.
Key Findings of the Study
Based on type, the liquid sub-segment emerged as the global leader in 2022 and powder sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.Based on application, the antioxidants sub-segment emerged as the global leader in 2022 and energy supplements sub-segment is predicted to show the fastest growth in the upcoming years.
Based on end user, the pharmaceuticals sub-segment emerged as the global leader in 2022 and food & beverages sub-segment is predicted to show the fastest growth in the upcoming years.
Based on region, the North America market registered the highest market share in 2022 and Asia-Pacific is predicted to show the fastest growth in the upcoming years.
Companies Mentioned
- Jungbunzlauer
- Shandong Xinhong Pharmaceutical Co., Ltd.
- Shandong Fuyuan Bio-Tech CO.LTD.
- Merck Millipore Corporation
- Shaoxing Marina Biotechnology Co.Ltd.
- Shandong Baisheng Biotechnology Co., Ltd.
- Roquette Freres
- Functional Food chem International Corporation
- Hubei Yitai Pharmaceutical Co.Ltd.
- Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
